[Synutra Reports Third Quarter and First Nine Months of Fiscal 2012 Financial Results 3Q12 Formula Sales Rose to 3 Year Record High of $99.8 million 3Q12 Gross Margin was 41.3% 3Q12 Net Income Increases to $10.3 million Qingdao, China and Rockville, Md. – February 9, 2012 – Synutra International, Inc. (NASDAQ: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in] []
[Synutra Reports Third Quarter and First Nine Months of Fiscal 2012 Financial Results 3Q12 Formula Sales Rose to 3 Year Record High of $99.8 million 3Q12 Gross Margin was 41.3% 3Q12 Net Income Increases to $10.3 million Qingdao, China and Rockville, Md. – February 9, 2012 – Synutra International, Inc. (NASDAQ: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in] []
[FORM 10-Q x For the quarterly period ended December 31, 2011 OR o For the transition period from SYNUTRA INTERNATIONAL, INC. DELAWARE 13-4306188 (State or Other Jurisdiction of Incorporation or Organization) I.R.S. Employer Identification No. 2275 Research Blvd., Suite 500 Rockville, Maryland 20850 (301) 840-3888 x o x o o Large accelerated filer x Accelerated filer] [I, Liang Zhang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Synutra International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [I, Weiguo Zhang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Synutra International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002]
[FORM 10-Q x For the quarterly period ended December 31, 2011 OR o For the transition period from SYNUTRA INTERNATIONAL, INC. DELAWARE 13-4306188 (State or Other Jurisdiction of Incorporation or Organization) I.R.S. Employer Identification No. 2275 Research Blvd., Suite 500 Rockville, Maryland 20850 (301) 840-3888 x o x o o Large accelerated filer x Accelerated filer] [I, Liang Zhang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Synutra International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [I, Weiguo Zhang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Synutra International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002]
[Synutra Provides Government Testing Results Regarding Infant Formula Safety Sales and Earnings Estimates Unchanged for 3Q12 Qingdao, China and Rockville, Md. – January 20, 2012 – Synutra International, Inc. (NASDAQ: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in China that produce, market and sell nutritional products for infants, children and adults, today announced the final findings by government authorities] []
[Synutra Provides Government Testing Results Regarding Infant Formula Safety Sales and Earnings Estimates Unchanged for 3Q12 Qingdao, China and Rockville, Md. – January 20, 2012 – Synutra International, Inc. (NASDAQ: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in China that produce, market and sell nutritional products for infants, children and adults, today announced the final findings by government authorities] []
[SYNUTRA INTERNATIONAL, INC. 2275 Research Boulevard, Suite 500]
[SYNUTRA INTERNATIONAL, INC. 2275 Research Boulevard, Suite 500]
[Synutra to Relocate Facilities and Corporate Campus Eyes Quarterly Net Sales Reaching Three-Year High Qingdao, China and Rockville, Md. – December 12, 2011 – Synutra International, Inc. (NASDAQ: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in China that produce, market and sell nutritional products for infants, children and adults, today announced the planned relocation of the Company’s R&D, customer] []
[Synutra to Relocate Facilities and Corporate Campus Eyes Quarterly Net Sales Reaching Three-Year High Qingdao, China and Rockville, Md. – December 12, 2011 – Synutra International, Inc. (NASDAQ: SYUT), (“Synutra” or the “Company”), which owns subsidiaries in China that produce, market and sell nutritional products for infants, children and adults, today announced the planned relocation of the Company’s R&D, customer] []
